Guidance for isolation precautions for mumps in the United States: A review of the scientific basis for policy changek

Clinical Infectious Diseases

Volumn 50, Issue 12, 2010, Pages 1619-1628

  Kutty, Preeta K ^a   Kyaw, Moe H ^a,e   Dayan, Gustavo H ^a,f   Brady, Michael T ^c   Bocchini Jr , Joseph A ^d   Reef, Susan E ^b   Bellini, William J ^a   Seward, Jane F ^a  

^a Division of Viral Diseases   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d LOUISIANA STATE UNIVERSITY   (United States)

^e Cambridge MA ^*  (United States)

^f SANOFI PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M; MUMPS VACCINE; VIRUS ANTIBODY; VIRUS RNA;

ANTIBODY DETECTION; HEALTH CARE POLICY; HOSPITALIZATION; HUMAN; INFECTION CONTROL; INFECTION RISK; INFECTION SENSITIVITY; MUMPS; MUMPS VIRUS; NONHUMAN; NOSE SECRETION; PAROTITIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RNA ANALYSIS; UNITED STATES; VACCINATION; VIRUS ISOLATION; VIRUS LOAD; VIRUS TRANSMISSION;

CROSS INFECTION; DISEASE OUTBREAKS; HEALTH PLANNING GUIDELINES; HEALTH POLICY; HUMANS; MUMPS; MUMPS VIRUS; PATIENT ISOLATION; POLICY MAKING; SALIVA; SPUTUM; UNITED STATES; VIRAL LOAD;

EID: 77952973263     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/652770     Document Type: Review

References (59)

1. Plotkin S. Mumps Vaccine. In: Plotkin SA, Orenstein WA, Offit PA, eds. Vaccines, 5th edition - expert consult. Philadelphia, PA: WB Saunders, 2008: 435-465.
2. Hviid A, Rubin S, Mühlemann K. Mumps. Lancet 2008; 371: 932-944.
3. Henle G, Henle W, Wendell KK, Rosenberg P. Isolation of mumps virus from human beings with induced apparent or inapparent infections. J Exp Med 1948; 88(2): 223-232.
4. Gordon JE, Kilham L. Ten years in the epidemiology of mumps. Am J Med Sci 1949; 218(3): 338-359.
5. Philip RN, Reinhard KR, Lackman DB. Observations on a mumps epidemic in a virgin population. Am J Hyg 1959; 69(2): 91-111.
6. Vicens CN, Norbega FT, Joseph M, Meyer MB, Evaluation of tests for the measurement of previous mumps infection and analysis of mumps experience by blood group. Am J Epidemiol 1966; 84(2): 371-373.
7. Centers for Disease Control and Prevention. Measles, mumps, and rubella - vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1998; 47(RR-8): 1-57.
8. Galazka AM, Robertson SE, Kraigher A. Mumps and mumps vaccine: a global review. Bull World Health Organ 1999; 77(1): 3-14.
9. Centers for Disease Control and Prevention. Mumps. In: Atkinson W, Hamborsky J, McIntyre L, Wolfe S, eds. Epidemiology and prevention of vaccine-preventable diseases 10th ed. Washington DC: Public Health Foundation, 2007: 149-158.
10. Meyer MB. An epidemiologic study of mumps; its spread in schools and families. Am J Hyg 1962; 75: 259-281.
11. Hayden GF, Preblud SR, Orenstein WA, Conrad JL. Current status of mumps and mumps vaccine in the United States. Pediatrics 1978; 62(6):965-969. (Pubitemid 9037494)
12. Centers for Disease Control and Prevention. Mumps vaccine. Recommendation of Public Health Service Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 1977; 26(48): 393-394.
13. Centers for Disease Control and Prevention. Provisional cases of infrequently reported notifiable diseases (<1,000 cases reported during the preceding year) - United States, week ending March 18, 2006 ( 11th week). MMWR Morb Mortal Wkly Rep 2006; 55: 301-328.
14. Centers for Disease Control and Prevention. Brief report: update: mumps activity-United States, January 1-October 7, 2006. MMWR Morb Mortal Wkly Rep 2006; 55(42): 1152-1153.
15. Dayan GH, Quinlisk MP, Parker AA, et al. Recent resurgence of mumps in the United States. N Engl J Med 2008; 358(15): 1580-1589.
16. Cortese MM, Jordan HT, Curns AT, et al. Mumps vaccine performance among university students during a mumps outbreak. Clin Infect Dis 2008; 46(8): 1172-1180.
17. Marin M, Quinlisk P, Shimabukuro T, Sawhney C, Brown C, Lebaron CW Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students -Iowa, 2006. Vaccine 2008; 26(29-30): 3601-3607.
18. American Academy of Pediatrics. Mumps. In: Pickering LK, Baker CJ, Long SS, McMillan JA, eds. Red Book: 2006 Report of the Committee on Infectious Disease 27th ed. Elk Grove Village, IL: American Academy of Pediatrics, 2006: 464-468.
19. American Academy of Pediatrics. Infection control in physicians' offices. Academy of Pediatrics. Committee on Infectious Diseases and Committee on Practices and Ambulatory Medicine. Pediatrics 2000; 105(6): 1361-1369.
20. American Academy of Pediatrics. Infection prevention and control in pediatric ambulatory settings. Pediatrics 2007; 120(3): 650-665.
21. Centers for Disease Control and Prevention. Updated recommendations for isolation of persons with mumps. MMWR Morb Mortal Wkly Rep 2008; 57(40): 1103-1105.
22. Simpson REH. Infectiousness of communicable diseases in the household (measles, chickenpox, and mumps). Lancet 1952; 2(6734): 549-554.
23. Black FL. A nationwide serum survey of United States military recruits, 1962. 3. Measles and mumps antibodies. Am J Hyg 1964; 80: 304-307.
24. Levitt LP, Mahoney DH Jr, Casey HL, Bond JO. Mumps in a general population. A sero-epidemiologic study. Am J Dis Child 1970; 120(2): 134-138.
25. Seigel M, Camp JL. An unusual outbreak of mumps. Am J Dis Child 1944; 68: 163-167.
26. Brunell PA, Brickman A, O'Hare D, Steinberg S. Ineffectiveness of isolation of patients as a method of preventing the spread of mumps. Failure of the mumps skin-test antigen to predict immune status. N Engl J Med 1968; 279(25): 1357-1361.
27. Fischer PR, Brunetti C, Welch V, Christenson JC. Nosocomial mumps: report of an outbreak and its control. Am J Infect Control 1996; 24(1): 13-18. (Pubitemid 26073003)
28. Yoshida N, Fujino M, Miyata A, et al. Mumps virus reinfection is not a rare event confirmed by reverse transcription loop-mediated isothermal amplification. J Med Virol 2008; 80(3): 517-523. (Pubitemid 351206903)
29. Utz JP, Kasel JA, Cramblett HG, Szwed CF, Parrott RH. Clinical and laboratory studies of mumps. I. Laboratory diagnosis by tissue-culture technics. N Engl J Med 1957; 257(11): 497-502.
30. Uchida K, Shinohara M, Shimada S, et al. Rapid and sensitive detection of mumps virus RNA directly from clinical samples by real-time PCR. J Med Virol 2005; 75(3): 470-474. (Pubitemid 40175916)
31. Shope TC, Hierholzer JC. Isolation of mumps virus. J Pediatr 1969; 74(5): 841-842.
32. Reina J, Ballesteros F, Mari M, Munar M. Evaluation of different continuous cell lines in the isolation of mumps virus by the shell vial method from clinical samples. J Clin Pathol 2001; 54(12):924-926. (Pubitemid 34032886)
33. Okafuji T, Yoshida N, Fujino M, et al. Rapid diagnostic method for detection of mumps virus genome by loop-mediated isothermal amplification. J Clin Microbiol 2005; 43(4): 1625-1631. (Pubitemid 40491199)
34. Leymaster GR, Wared TG. The direct isolation of mumps virus in chick embryos. J Clin Invest 1947; 26(6): 1188.
35. Knowles WA, Cohen BJ. Efficient isolation of mumps virus from a community outbreak using the marmoset lymphoblastoid cell line B95a. J Virol Methods 2001; 96(l): 93-96.
36. Johnson CD, Goodpasteur EW An investigation of the etiology of mumps. J Exp Med 1934; 59: 1-20.
37. Isomura S, Asano Y, An Sunhon, Tanaka E, Suzuki S. Epidemiologic studies on mumps. I. Spread of mumps in families. Acta Paediatr Jpn 1975; 17(2): 7-12.
38. Ennis FA, Jackson D. Isolation of virus during the incubation period of mumps infection. J Pediatr 1968; 72(4): 536-537.
39. Chiba Y, Horino K, Umetsu M, Wataya Y, Chiba S. Virus excretion and antibody response in saliva in natural mumps. Tohoku J Exp Med 1973; 111(3): 229-238.
40. Hook EW Jr, Poole SP, Friedewald WF. Virus isolation and serologic studies on patients with clinical mumps. J Infect Dis 1949; 84(3): 230-234.
41. Polgreen PM, Bohnett LC, Cavanaugh JE, et al. The duration of mumps virus shedding after the onset of symptoms. Clin Infect Dis 2008; 46(9): 1447-1449. (Pubitemid 351589948)
42. Cusi MG, Bianchi S, Valassina M, Santini L, Arnetoli M, Valensin PE. Rapid detection and typing of circulating mumps virus by reverse transcription/polymerase chain reaction. Res Virol 1996; 147(4): 227-232.
43. Krause CH, Eastick K, Ogilvie MM. Real-time PCR for mumps diagnosis on clinical specimens-comparison with results of conventional methods of virus detection and nested PCR. J Clin Virol 2006; 37(3): 184-189.
44. Jin L, Feng Y, Parry R, Cui A, Lu Y. Real-time PCR and its application to mumps rapid diagnosis. J Med Virol 2007; 79(11): 1761-1767.
45. Siegel JD, Rhinehart E, Jackson M, Chiarello L. 2007 Guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control 2007; 35(suppl 2): S65-S164.
46. De Boer AW, de Vaan GAM. Mild course of mumps in patients with acute lymphoblastic leukemia. Eur J Pediatr 1989; 148: 618-619.
47. Baas MC, van Donselaar KA Florquin S, van Binnendijk RS, Ten Berge IJ, Bemelman FJ. Mumps: not an innocent bystander in solid organ transplantation. Am J Transplant 2009;9(9):2186-2189.
48. Weber SH MD, Miller P, Tilzer L, Kliethermes J, Horvat RT. Hospital and clinical laboratory response to mumps exposures. Sci Lab Med 2007; 38(5): 285-288.
49. Wharton M, Cochi SL, Hutcheson RH, Schaffner W. Mumps transmission in hospitals. Arch Intern Med 1990; 150(l): 47-49.
50. Sosin DM, Cochi SL, Gunn RA, Jennings CE, Preblud SR. Changing epidemiology of mumps and its impact on university campuses. Pediatrics 1989; 84(5): 779-784.
51. Soud FA, Cortese MM, Curns AT, et al. Isolation compliance among university students during a mumps outbreak, Kansas 2006. Epidemiol Infect 2009; 137(l): 30-37.
52. Bitsko RH, Cortese MM, Dayan GH, et al. Detection of RNA of mumps virus during an outbreak in a population with a high level of measles, mumps, and rubella vaccine coverage. J Clin Microbiol 2008; 46(3): 1101-1103.
53. Jin L, Vyse A, Brown DW The role of RT-PCR assay of oral fluid for diagnosis and surveillance of measles, mumps and rubella. Bull World Health Organ 2002;80(1):76-77. (Pubitemid3 4151513)
54. Roush SW, Murphy TV. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA 2007; 298(18): 2155-2163.
55. Harling R, White JM, Ramsay ME, Macsween KF, van den Bosch C. The effectiveness of the mumps component of the MMR vaccine: a case control study. Vaccine 2005; 23(31): 4070-4074.
56. Chamot E, Toscani L, Egger P, Germann D, Bourquin C. Estimation of the efficacy of three strains of mumps vaccines during an epidemic of mumps in the Geneva canton (Switzerland) [in French]. Rev Epidemiol Sante Publique 1998;46(2):100-107.(Pubitemid 28191574)
57. Chaiken BP, Williams NM, Preblud SR, Parkin W, Altman R. The effect of a school entry law on mumps activity in a school district. JAMA 1987; 257(18): 2455-2458.
58. Cohen C, White JM, Savage EJ, et al. Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England. Emerg Infect Dis 2007; 13(1): 12-17.
59. Centers for Disease Control and Prevention. Notice to readers: updated recommendations of the Advisory Committee on Immunization Practices (ACIP) for the control and elimination of mumps. MMWR Morb Mortal Wky Rep 2006; 55(22): 629-630.